Rapports

Aspen Pharmacare Holdings Ltd (APN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Rapport
Titre
Aspen Pharmacare Holdings Ltd (APN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
237.50EUR
Langue
English
Pages
61
Secteur
Santé
Date
Avril 2016
Pays
Afrique du Sud
Type de Produit
Company report
Description du rapport

Aspen Pharmacare Holdings Ltd (Aspen) manufactures and supplies branded, generic and OTC pharmaceuticals. It also supplies consumer and nutritional products. The company manufactures a wide range of products including capsules, tablets, eye drops, injectables including lyophilized vials, form-filled seals, oral contraceptives, creams, ointments, suppositories, liquids, infant nutritional products and specialist active pharmaceutical ingredients (APIs). Its generic drugs include anti-depressants, anti-inflammatory agents, gastro-intestinal agents, analgesics, anti-hypertensives and bronchodilators. The company develops its generic pipeline in collaboration with global pharmaceutical companies and research facilities. Aspen offers its products in Australia, Asia, Europe, North America, South America, the Middle East and Africa. Aspen is headquartered in Durban, South Africa.

Aspen Pharmacare Holdings Ltd (APN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you c

Table des matières

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 15

Asset Purchase 15

Aspen Global to Acquire Rights to Hydroxyprogesterone Caproate Injection form McGuff Pharma 15

Aspen Pharmacare Acquires Southern African Operations and Product Rights from Norgine 16

Aspen Pharmacare Plans to Acquire Infant Nutrition Business 17

Aspen Pharmacare to Acquire Rights to Mono-Embolex from Novartis 18

Aspen Pharma Acquires Infant Nutritional Businesses from Nestle for USD180 Million 19

Aspen Acquires Portfolio of Drugs from Merck for USD600 Million 21

Aspen Pharmacare Completes Acquisition Of Thrombosis Brands And Manufacturing Facility From GlaxoSmithKline For US$1.13 Billion 23

Aspen Acquires Active Pharmaceutical Ingredients Business From Merck 25

Aspen Completes Acquisition Of Non-Core Australian Drugs From GlaxoSmithKline For US$257 Million 26

Aspen Pharmacare Completes Acquisition Of Non-Core OTC Brands From GlaxoSmithKline For US$263 Million 27

Aspen Pharmacare Acquires Pharma Division Of Sigma Pharma 29

Partnerships 31

Cardiome Pharma Enters into Co-Marketing Agreement with Aspen Pharma for Brinavess 31

Navamedic Amends Distribution Agreement With Aspen Pharma 32

Cipla Plans To Enters Into Co-Development Agreement With Aspen Pharmacare 33

Navamedic Enters Into Distribution Agreement With Aspen Pharma 34

Licensing Agreements 35

TesoRx Pharma Enters into Licensing Agreement with Aspen Global 35

Tibotec Pharma Enters Into Licensing Agreement With Aspen Pharmacare For TMC278 36

Indoco Enters Into Licensing Agreement With ASPEN 38

Asset Transactions 39

Endo International Acquires Portfolio of Branded and Generic Products 39

Strides Arcolab Acquires Generic Pharma Business and Related Assets from Aspen Pharmacare for USD210 Million 40

Strides Arcolab Acquires Prescription Products from Aspen Global for USD92 million 41

Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 42

Mylan to Acquire Rights to Arixtra Injection from Aspen Global 43

Perrigo Acquires OTC Products From Aspen Global For US$51 Million 45

Lupin Acquires Worldwide Rights To Goanna Brand From Aspen Pharmacare 46

Strides Acquires Brazilian Manufacturing Facility From Aspen Pharmacare 47

Acquisition 48

GlaxoSmithKline to Acquire 25% Stake in Aspen Japan 48

GlaxoSmithKline Completes Sale Of 6.19% Stake In Aspen Pharmacare For US$696.5 Million 49

Aspen Pharmacare Completes Acquisition Of Remaining 40% Stake In Shelys Africa For US$18.6 Million 51

Merck Terminates Sale Of Its Stake In Organon BioSciences 52

Aspen Pharmacare To Acquire Latin American Companies 54

Strides Acquires 50% Stake In Onco Therapies And Onco Labs From Aspen 55

Aspen Pharmacare Holdings Ltd - Key Competitors 56

Key Employees 57

Locations And Subsidiaries 58

Head Office 58

Other Locations & Subsidiaries 58

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61

Description de l'éditeur

GlobalData is the premier source of actionable insight into the healthcare industry. With the combined expertise of more than 1,000 researchers, market analysts and consultants, we provide high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

Combining precision with innovation, our research and consulting solutions ensure our clients stay at the forefront of their markets by integrating accurate market forecasts and analysis on the latest trends and developments with the unrivalled expertise of our analyst teams. Among other benefits, our informed industry perspectives help clients understand how to generate the maximum return from their key markets, identify opportunities from emerging trends, and devise strategies for growth with confidence.

 

Contact:  Partner Supportpartnersupport@globaldata.com

                 Sunil Sethia ssethia@globaldata.com